Does ABIRATERONE Cause Thrombocytopenia? 228 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 228 reports of Thrombocytopenia have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 0.7% of all adverse event reports for ABIRATERONE.
228
Reports of Thrombocytopenia with ABIRATERONE
0.7%
of all ABIRATERONE reports
35
Deaths
60
Hospitalizations
How Dangerous Is Thrombocytopenia From ABIRATERONE?
Of the 228 reports, 35 (15.4%) resulted in death, 60 (26.3%) required hospitalization, and 17 (7.5%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE. However, 228 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Therapy cessation (1,602)
Prostatic specific antigen increased (1,581)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which ABIRATERONE Alternatives Have Lower Thrombocytopenia Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB